Prospective Liver Study

Liver Cancer Prognosis Investigation Study

NCT06623734 ·Status: NOT_YET_RECRUITING

Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing

NCT05520788 ·Status: RECRUITING

Recurrent Liver Cancer: Reconceptualization and Reevaluation

NCT06430983 ·Status: RECRUITING

Navigating the Clinical Trial Process for Hepatocellular Carcinoma

NCT05859945 ·Status: NOT_YET_RECRUITING

Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma

NCT02513199 ·Status: COMPLETED ·Phase: PHASE2

A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer

NCT05371873 ·Status: UNKNOWN

A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area

NCT00913757 ·Status: COMPLETED

Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid

NCT06699524 ·Status: ACTIVE_NOT_RECRUITING

A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy

NCT02959151 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer

NCT01356628 ·Status: COMPLETED ·Phase: PHASE2

Circulating Tumor Cells for Hepatocellular Carcinoma

NCT01930383 ·Status: UNKNOWN

Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation

NCT05910970 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

NCT05103904 ·Status: TERMINATED ·Phase: PHASE2

National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

NCT04145141 ·Status: ACTIVE_NOT_RECRUITING

The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.

NCT07233759 ·Status: ACTIVE_NOT_RECRUITING

Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt

NCT02990351 ·Status: COMPLETED

Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)

NCT05277675 ·Status: UNKNOWN ·Phase: NA

Effects of Antiviral Therapy on Patients With HBV-related HCC

NCT05406089 ·Status: COMPLETED

Vaccine Therapy in Treating Patients With Liver Cancer

NCT00005629 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients

NCT04933435 ·Status: RECRUITING ·Phase: NA

Blood Sample Collection for Experimental Blood Test to Track Liver Cancer

NCT04720430 ·Status: COMPLETED

Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC

NCT02563158 ·Status: UNKNOWN ·Phase: NA

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

NCT05292443 ·Status: WITHDRAWN

Lenvatinib Therapy in HCC Patients After LDLT

NCT05572528 ·Status: RECRUITING

Sintilimab Combined With Lenvatinib Versus HAIC for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma

NCT05519410 ·Status: UNKNOWN ·Phase: PHASE2